Kathleen M Huerter, CRNA | |
9100 W 74th St, Shawnee Mission, KS 66204-4004 | |
(913) 632-2230 | |
(913) 632-2297 |
Full Name | Kathleen M Huerter |
---|---|
Gender | Female |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 35 Years |
Location | 9100 W 74th St, Shawnee Mission, Kansas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164490827 | NPI | - | NPPES |
430025796 | Other | KS | RR MEDICARE |
26915018 | Other | KS | BCBS KC |
100326280B | Medicaid | KS | |
913858114 | Medicaid | MO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | 1360740041 (Kansas) | Secondary |
367500000X | Nurse Anesthetist, Certified Registered | 54406 (Kansas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Adventhealth Shawnee Mission | Shawnee mission, KS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Midwest Anesthesia Associates, Pa | 4981597838 | 83 |
News Archive
UE LifeSciences Inc. (UELS), a medical device manufacturer focused on providing novel breast cancer screening solutions, announced today that it has received market clearance from the U.S. Food and Drug Administration (FDA) for its NoTouch BreastScan™ device. NoTouch BreastScan™ is a contactless breast-imaging tool cleared by the FDA specifically for adjunctive diagnostic screening for the detection of breast cancer.
Archer Biosciences, Inc. announced that the trial of its novel, proprietary drug TPI-287 (an abeotaxane) for the treatment of metastatic melanoma has initiated a third drug-escalation cohort. The primary objective of this study is to determine the safety, tolerability and maximum tolerated dose (MTD) of TPI-287 in combination with temozolomide (TMZ) in adult patients with metastatic melanoma.
Never before have we experienced social isolation on a massive scale as we have during the evolving COVID-19 pandemic.
Takeda Pharmaceutical Company Limited today announced that it will present Phase 3 data from the TOURMALINE-MM1 ixazomib clinical trial at the 57th American Society of Hematology (ASH) Annual Meeting to be held in Orlando, Florida from December 5 to 8, 2015.
yeast or phages act not only to tag and target but also to exchange specific genes in DNA
› Verified 5 days ago
Entity Name | Midwest Anesthesia Associates, Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1336192392 PECOS PAC ID: 4981597838 Enrollment ID: O20040204000690 |
News Archive
UE LifeSciences Inc. (UELS), a medical device manufacturer focused on providing novel breast cancer screening solutions, announced today that it has received market clearance from the U.S. Food and Drug Administration (FDA) for its NoTouch BreastScan™ device. NoTouch BreastScan™ is a contactless breast-imaging tool cleared by the FDA specifically for adjunctive diagnostic screening for the detection of breast cancer.
Archer Biosciences, Inc. announced that the trial of its novel, proprietary drug TPI-287 (an abeotaxane) for the treatment of metastatic melanoma has initiated a third drug-escalation cohort. The primary objective of this study is to determine the safety, tolerability and maximum tolerated dose (MTD) of TPI-287 in combination with temozolomide (TMZ) in adult patients with metastatic melanoma.
Never before have we experienced social isolation on a massive scale as we have during the evolving COVID-19 pandemic.
Takeda Pharmaceutical Company Limited today announced that it will present Phase 3 data from the TOURMALINE-MM1 ixazomib clinical trial at the 57th American Society of Hematology (ASH) Annual Meeting to be held in Orlando, Florida from December 5 to 8, 2015.
yeast or phages act not only to tag and target but also to exchange specific genes in DNA
› Verified 5 days ago
Entity Name | Anesthesia Associates Of Kansas City Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1174504732 PECOS PAC ID: 1951206168 Enrollment ID: O20050721001069 |
News Archive
UE LifeSciences Inc. (UELS), a medical device manufacturer focused on providing novel breast cancer screening solutions, announced today that it has received market clearance from the U.S. Food and Drug Administration (FDA) for its NoTouch BreastScan™ device. NoTouch BreastScan™ is a contactless breast-imaging tool cleared by the FDA specifically for adjunctive diagnostic screening for the detection of breast cancer.
Archer Biosciences, Inc. announced that the trial of its novel, proprietary drug TPI-287 (an abeotaxane) for the treatment of metastatic melanoma has initiated a third drug-escalation cohort. The primary objective of this study is to determine the safety, tolerability and maximum tolerated dose (MTD) of TPI-287 in combination with temozolomide (TMZ) in adult patients with metastatic melanoma.
Never before have we experienced social isolation on a massive scale as we have during the evolving COVID-19 pandemic.
Takeda Pharmaceutical Company Limited today announced that it will present Phase 3 data from the TOURMALINE-MM1 ixazomib clinical trial at the 57th American Society of Hematology (ASH) Annual Meeting to be held in Orlando, Florida from December 5 to 8, 2015.
yeast or phages act not only to tag and target but also to exchange specific genes in DNA
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Kathleen M Huerter, CRNA Po Box 411895, Kansas City, MO 64141-1895 Ph: (913) 632-2230 | Kathleen M Huerter, CRNA 9100 W 74th St, Shawnee Mission, KS 66204-4004 Ph: (913) 632-2230 |
News Archive
UE LifeSciences Inc. (UELS), a medical device manufacturer focused on providing novel breast cancer screening solutions, announced today that it has received market clearance from the U.S. Food and Drug Administration (FDA) for its NoTouch BreastScan™ device. NoTouch BreastScan™ is a contactless breast-imaging tool cleared by the FDA specifically for adjunctive diagnostic screening for the detection of breast cancer.
Archer Biosciences, Inc. announced that the trial of its novel, proprietary drug TPI-287 (an abeotaxane) for the treatment of metastatic melanoma has initiated a third drug-escalation cohort. The primary objective of this study is to determine the safety, tolerability and maximum tolerated dose (MTD) of TPI-287 in combination with temozolomide (TMZ) in adult patients with metastatic melanoma.
Never before have we experienced social isolation on a massive scale as we have during the evolving COVID-19 pandemic.
Takeda Pharmaceutical Company Limited today announced that it will present Phase 3 data from the TOURMALINE-MM1 ixazomib clinical trial at the 57th American Society of Hematology (ASH) Annual Meeting to be held in Orlando, Florida from December 5 to 8, 2015.
yeast or phages act not only to tag and target but also to exchange specific genes in DNA
› Verified 5 days ago
Robb A. Aerni, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-676-2679 Fax: 913-789-3191 | |
Lisa A Noyes, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-632-2230 Fax: 913-632-2297 | |
Marlene F. Bailey, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-632-2230 Fax: 913-632-2297 | |
Erin M. Steinbrink, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-632-2230 Fax: 913-632-2297 | |
Sarah-grace Miller Hamm, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-632-2230 Fax: 913-632-2297 | |
Stephanie A. Klamm, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-676-2679 Fax: 913-789-3191 | |
Danelle Lynn Diorio, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-632-2230 Fax: 913-632-2297 |